Huitt Tracey
Fortune : 16 300 $ au 30/09/2026
Fortune : 16 300 $ au 30/09/2026
Mr. Huitt Tracey is an Independent Director at Black Pine Resources Corp., an Independent Director at Iconic Minerals Ltd. and a Head-Investor Relations at NervGen Pharma Corp.
He is on the Board of Directors at Black Pine Resources Corp.
and Iconic Minerals Ltd. Mr. Tracey was previously employed as an Independent Director by Anquiro Ventures Ltd. and an Independent Director by Curlew Lake Resources, Inc. He also served on the board at Quantum Solar Power Corp.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,65 % | 23/02/2026 | 200 000 ( 0,65 % ) | 12 000 $ | 30/09/2026 |
ICONIC MINERALS LTD 0,05 % | 02/04/2026 | 100 000 ( 0,05 % ) | 4 300 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ICONIC MINERALS LTD. | Directeur/Membre du Conseil | 23/07/2014 |
| NERVGEN PHARMA CORP. | Investor Relations Contact | - |
| Sociétés | Poste | Fin |
|---|---|---|
| C21 INVESTMENTS INC. | Directeur/Membre du Conseil | 18/06/2015 |
| QUANTUM SOLAR PWR | Directeur/Membre du Conseil | 16/07/2010 |
| BLACK PINE RESOURCES CORP. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Iconic Minerals Ltd.
Iconic Minerals Ltd. Chemicals: AgriculturalProcess Industries Explores lithium projects | Process Industries |
C21 Investments, Inc.
C21 Investments, Inc. Agricultural Commodities/MillingProcess Industries Engages in cultivation, processing and distribution of cannabis | Process Industries |
Quantum Solar Power Corp.
Quantum Solar Power Corp. Electric UtilitiesUtilities Develops and commercializes solar power technology | Utilities |
Anquiro Ventures Ltd.
Anquiro Ventures Ltd. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
NervGen Pharma Corp.
NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national